ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Alamar Biosciences, Inc.
36.57
+8.58
30.65%
盤後:
36.40
-0.1700
-0.46%
19:55 EDT
成交量:
155.83萬
成交額:
5,533.66萬
市值:
25.35億
市盈率:
-58.33
高:
38.54
開:
29.00
低:
28.03
收:
27.99
52周最高:
38.54
52周最低:
18.85
股本:
6,931.12萬
流通股本:
1,293.75萬
量比:
6.92
換手率:
12.05%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.6270
每股收益(LYR):
-2.5873
淨資產收益率:
-33.57%
總資產收益率:
-13.53%
市淨率:
-14.23
市盈率(LYR):
-14.13
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
Alamar Biosciences攜手阿爾茨海默病數據倡議與Gates Ventures,深化全球合作
美股速递
·
昨天
財報前瞻|Alamar Biosciences, Inc.本季度營收預計約2,593.98萬美元,機構觀點偏看多
财报Agent
·
08/03
高盛系免疫療法新鋭Attovia(ATTO.US)衝刺納斯達克:最高募資2.125億美元,成生物科技IPO熱潮最新註腳
智通财经
·
07/30
Alzpath 擴大與 Alamar Biosciences 的戰略合作,推動阿爾茨海默病臨床診斷進步
美股速递
·
07/23
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ALMR"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALMR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMR\",,,,,undefined,":{"symbol":"ALMR","market":"US","secType":"STK","nameCN":"Alamar Biosciences, Inc.","latestPrice":36.57,"timestamp":1786478400000,"preClose":27.99,"halted":0,"volume":1558330,"hourTrading":{"tag":"盘后","latestPrice":36.4,"preClose":36.57,"latestTime":"19:55 EDT","volume":17216,"amount":629609.2651,"timestamp":1786492501007,"change":-0.17,"changeRate":-0.004649,"amplitude":0.0484},"delay":0,"changeRate":0.3065380493033227,"floatShares":12937500,"shares":69311200,"eps":-0.627,"marketStatus":"未開盤","change":8.58,"latestTime":"08-11 16:00:00 EDT","open":29,"high":38.54,"low":28.03,"amount":55336645.80759001,"amplitude":0.375491,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.627,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1786521600000},"marketStatusCode":0,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":27.99,"preHourTrading":{"tag":"盘前","latestPrice":29,"preClose":27.99,"latestTime":"09:27 EDT","volume":299,"amount":8473.014459,"timestamp":1786454830025,"change":1.01,"changeRate":0.036084,"amplitude":0.036084},"postHourTrading":{"tag":"盘后","latestPrice":36.4,"preClose":36.57,"latestTime":"19:55 EDT","volume":17216,"amount":629609.2651,"timestamp":1786492501007,"change":-0.17,"changeRate":-0.004649,"amplitude":0.0484},"volumeRatio":6.921783},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMR\",,,,,undefined,":{"symbol":"ALMR","floatShares":12937500,"roa":"-13.53%","roe":"-33.57%","lyrEps":-2.587299,"volumeRatio":6.921783,"shares":69311200,"dividePrice":0,"high":38.54,"amplitude":0.375491,"preClose":27.99,"low":28.03,"week52Low":18.845,"pbRate":"-14.23","psRate":"29.08","week52High":38.54,"institutionHeld":0,"latestPrice":36.57,"eps":-0.627,"divideRate":0,"volume":1558330,"delay":0,"ttmEps":-0.627,"open":29,"prevYearClose":17,"prevWeekClose":28.46,"prevMonthClose":25.36,"prevQuarterClose":27.09,"fiveDayClose":27.11,"twentyDayClose":27.05,"sixtyDayClose":22.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALMR\",params:#limit:5,,,undefined,":[{"date":"2026-08-10","symbol":"ALMR","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":-0.36,"defaultRemindTime":1786392000000,"name":null,"time":"盤後","dateTimestamp":1786334400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALMR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALMR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.4,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":5,"updateTime":1779422400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALMR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALMR","date":"2026-08-10","current":-57.631579,"percent":0.197183,"low":-61.051551,"twenty":-45.349934,"median":-40.062933,"eighty":-33.17246,"high":-30.427746,"avg":-41.276042,"sd":8.3599,"marketCap":1972596353},"quantilePoints":[{"date":"2026-05-01","current":-57.277289,"twenty":-59.990183,"median":-57.277289,"eighty":-56.655108,"marketCap":1707951482},{"date":"2026-05-08","current":-54.120633,"twenty":-59.175857,"median":-56.408065,"eighty":-54.495772,"marketCap":1613823165},{"date":"2026-05-15","current":-35.878919,"twenty":-57.629553,"median":-54.669617,"eighty":-53.99338,"marketCap":1560194796},{"date":"2026-05-22","current":-35.066025,"twenty":-56.9113,"median":-54.440874,"eighty":-34.919385,"marketCap":1524846092},{"date":"2026-05-29","current":-31.495666,"twenty":-56.325717,"median":-53.802501,"eighty":-32.467951,"marketCap":1369589035},{"date":"2026-06-05","current":-34.253131,"twenty":-55.282649,"median":-35.878919,"eighty":-32.646469,"marketCap":1489497387},{"date":"2026-06-12","current":-35.368868,"twenty":-54.724515,"median":-34.699426,"eighty":-32.401007,"marketCap":1538015217},{"date":"2026-06-18","current":-32.196986,"twenty":-54.651317,"median":-34.308917,"eighty":-32.158732,"marketCap":1400085957},{"date":"2026-06-26","current":-42.828368,"twenty":-54.587269,"median":-35.066025,"eighty":-32.350002,"marketCap":1862391567},{"date":"2026-07-02","current":-41.648874,"twenty":-54.495772,"median":-35.368868,"eighty":-32.60184,"marketCap":1811101290},{"date":"2026-07-10","current":-42.206743,"twenty":-54.303628,"median":-36.436788,"eighty":-32.691099,"marketCap":1835360205},{"date":"2026-07-17","current":-39.76806,"twenty":-53.99338,"median":-39.098618,"eighty":-32.700662,"marketCap":1729314090},{"date":"2026-07-24","current":-41.266336,"twenty":-53.295956,"median":-39.903543,"eighty":-32.786733,"marketCap":1794466605},{"date":"2026-07-31","current":-39.959329,"twenty":-52.542305,"median":-39.576791,"eighty":-32.978002,"marketCap":1737631433},{"date":"2026-08-07","current":-44.788877,"twenty":-45.298929,"median":-40.039025,"eighty":-33.153333,"marketCap":1947644326},{"date":"2026-08-10","current":-45.362685,"twenty":-45.349934,"median":-40.062933,"eighty":-33.17246,"marketCap":1972596353}],"updateTime":1786478292481},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALMR\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1165363440","title":"Alamar Biosciences攜手阿爾茨海默病數據倡議與Gates Ventures,深化全球合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1165363440","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165363440?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392312,"startTime":"0","endTime":"0","summary":"Alamar Biosciences(简称:ALMR)正积极拓展其全球战略版图,与阿尔茨海默病数据倡议(Alzheimer’s Disease Data Initiative)以及Gates Ventures达成更广泛的合作伙伴关系。这一举措,旨在通过数据共享与技术协同,加速对阿尔茨海默病的研究与疗法开发。合作方将整合各自资源,推动全球范围内的疾病数据整合与创新诊断工具的应用。Alamar Biosciences的管理层表示,此合作将进一步提升其平台在神经退行性疾病领域的应用潜力,为患者群体带来更精准的诊断方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130899284","title":"財報前瞻|Alamar Biosciences, Inc.本季度營收預計約2,593.98萬美元,機構觀點偏看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1130899284","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130899284?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 08:55","pubTimestamp":1785718537,"startTime":"0","endTime":"0","summary":"Alamar Biosciences, Inc.将于2026年08月10日盘后发布2026年第二季度财报,市场聚焦收入延续性与亏损收窄节奏。市场一致预期显示,本季度Alamar Biosciences, Inc.营收预计为2,593.98万美元,同比增速记录为0.00%;调整后每股收益预计为—0.33美元,同比增速记录为0.00%,公司层面暂未披露本季度的毛利率与净利率指引,亦未提供本季度收入指引。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|Alamar Biosciences, Inc.本季度营收预计约2,593.98万美元,机构观点偏看多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655844683","title":"高盛系免疫療法新鋭Attovia(ATTO.US)衝刺納斯達克:最高募資2.125億美元,成生物科技IPO熱潮最新註腳","url":"https://stock-news.laohu8.com/highlight/detail?id=2655844683","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655844683?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 11:39","pubTimestamp":1785382784,"startTime":"0","endTime":"0","summary":"发行概览:从1亿美元到2.125亿美元,需求推动规模扩大Attovia于7月14日首次提交IPO申请时,计划募资约1亿美元。以区间中点计算,Attovia的完全稀释市值约为6.49亿美元。截至2026年3月31日,公司累计融资达2.558亿美元。Alamar至今仍是Attovia的重要股东。市场背景:生物科技IPO的“黄金窗口”Attovia选择此时上市绝非偶然——2026年正成为生物科技IPO的“大年”。至少还有六家生物科技公司已在7月提交IPO申请,预计将在夏末前完成定价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1473953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4226","LU0096364046.USD","LU0106831901.USD","LU0061475181.USD","LU1868837300.USD","LU2471134523.USD","LU2237438978.USD","LU1868836914.USD","LU1804176565.USD","LU2237443549.SGD","LU1791807156.HKD","LU0345770308.USD","LU2237443895.HKD","LU1868837136.USD","LU2237443978.SGD","LU1894683264.USD","LU2237443465.HKD","IE00B19Z3B42.SGD","LU2237443622.USD","LU2471134796.USD","LU0942090050.USD","BK4550","BK4552","BK4588","IE0002270589.USD","IE00B19Z3581.USD","BK4533","LU2750360641.GBP","IE0034235188.USD","LU1894683348.USD","IE00BSNM7G36.USD","GS","LU0251142724.SGD","BK4121","LU0742534661.SGD","LU2471134879.HKD","LU2471134952.CNY","LU2265009873.SGD","LU0345770993.USD","LU1868836591.USD","IE0004091025.USD","LU0048573561.USD","BK4504","ATTO","BK4585","IE00BFXG1179.USD","LU0251131958.USD","GSX","BK4143","LU1868836757.USD","LU2237443382.USD","BK4127","IE0004086264.USD","LU0868494617.USD","ALMR","BK4516","LU1668664300.SGD","LU2750360997.AUD","LU0868494708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120675244","title":"Alzpath 擴大與 Alamar Biosciences 的戰略合作,推動阿爾茨海默病臨床診斷進步","url":"https://stock-news.laohu8.com/highlight/detail?id=1120675244","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120675244?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 20:35","pubTimestamp":1784810143,"startTime":"0","endTime":"0","summary":"Alzpath 宣布,已进一步扩展与 Alamar Biosciences 的战略合作协议。双方旨在携手推进阿尔茨海默病的临床诊断技术。通过此次深化合作,Alzpath 将充分利用 Alamar Biosciences 的创新平台,加速相关诊断工具的开发与应用。这一举措有望为阿尔茨海默病的早期检测与精准诊断带来显著突破,从而更好地满足患者和医疗系统的迫切需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ALMR\",params:#limit:6,delay:false,,,undefined,":[]}}